A biology-driven approach to drug discovery excellence
Delivering Next Generation Medicines
NGM Bio is a research-driven, clinical-stage biopharmaceutical company that has generated a promising pipeline of therapeutics addressing cardio-metabolic and liver diseases. Our deep expertise in drug discovery and translational development, coupled with the significant resources from our partnership with Merck, is driving the development of transformational medicines that dramatically improve human health. Learn more.